Intervention Review

Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer

  1. Sanjeev Deva1,*,
  2. Michael Jameson2

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 15 AUG 2012

Assessed as up-to-date: 16 DEC 2011

DOI: 10.1002/14651858.CD007814.pub2

How to Cite

Deva S, Jameson M. Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer. Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD007814. DOI: 10.1002/14651858.CD007814.pub2.

Author Information

  1. 1

    Auckland Hospital, Cancer and Blood, Auckland, New Zealand

  2. 2

    Waikato Hospital, Oncology Department, Hamilton, Waikato, New Zealand

*Sanjeev Deva, Cancer and Blood, Auckland Hospital, Park Road, Grafton, Auckland, New Zealand.

Publication History

  1. Publication Status: New
  2. Published Online: 15 AUG 2012


Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions and you will be able to log in to access content. Some users may also log in directly via OpenAthens.

Please note that there are currently a number of duplicate entries in the list of institutions. We are actively working on fixing this issue and apologize for any inconvenience caused.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.